Shopping Cart
- Remove All
- Your shopping cart is currently empty
Compounds 6B and 14g demonstrated significant inhibitory effects on the tumor-related subtype [HCA IX] with low nanomolar potency, while 6K was effective on [HCA XII]. These compounds can be considered leading molecules for developing future cancer therapeutic drugs based on new mechanisms of action.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
25 mg | $1,520 | 6-8 weeks | |
50 mg | $1,980 | 6-8 weeks | |
100 mg | $2,500 | 6-8 weeks |
Description | Compounds 6B and 14g demonstrated significant inhibitory effects on the tumor-related subtype [HCA IX] with low nanomolar potency, while 6K was effective on [HCA XII]. These compounds can be considered leading molecules for developing future cancer therapeutic drugs based on new mechanisms of action. |
Molecular Weight | 352.36 |
Formula | C18H12N2O4S |
Cas No. | 2451479-86-8 |
Storage | Shipping with blue ice. |
Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.